TARDBP and amyotrophic lateral sclerosis: To achieve this, we focused on individuals with high likelihood (clinical ALS) or definite (pathology confirmed or genetic variants) TDP-43 pathology, and we trained a SuStaIn model on baseline cortical and subcortical volume data.